Search bioRxiv⌕ Search

Biology subjects

Fatafta, H.

Publications and source records attributed to Fatafta, H..

2 recordsLinked to original sources

Structural dissection of the first events following membrane binding of the islet amyloid polypeptide

Amyloid forming proteins are involved in many pathologies and often belong to the class of intrinsically disordered proteins. One of these proteins is the islet amyloid polypeptide (IAPP), which is the main constituent of the amyloid fibrils found in the pancreas of type 2 diabetes patients. The molecular mechanism of IAPP-induced cell death is not yet understood, however it is known that cell membrane plays a dual role, being a catalyst of IAPP aggregation and the target of IAPP toxicity. Using FTIR spectroscopy, transmission electron microscopy, and molecular dynamics simulations we investigate the very first molecular steps following IAPP binding to a lipid membrane. In particular, we assess the combined effects of the charge state of amino-acid residue 18 and the IAPP-membrane interactions on the structures of monomeric and aggregated IAPP. Both our experiments and simulations reveal distinct IAPP-membrane interaction modes for the various IAPP variants. Membrane binding causes IAPP to fold into an amphipathic helix, which in the case of H18K- and H18R-IAPP can easily insert into the membrane. For all IAPP variants but H18E-IAPP, the membrane-bound -helical structure is an intermediate on the way to IAPP amyloid aggregation, while H18E-IAPP remains in a stable helical conformation. The fibrillar aggregates of wild-type IAPP and H18K-IAPP are dominated by an antiparallel {beta}-sheet conformation, while H18R- and H18A-IAPP exhibit both antiparallel and parallel {beta}-sheets as well as amorphous aggregates. In summary, our results emphasize the importance of residue 18 for the structure and membrane interaction of IAPP. This residue is thus a good target for destabilizing amyloid fibrils of IAPP and inhibit its toxic actions by possible therapeutic molecules.

biophysics↗

Amyloid-β peptide dimers undergo a random coil to β-sheet transition in the aqueous phase but not at the neuronal membrane

AO_SCPLOWBSTRACTC_SCPLOWThe aggregation of amyloid {beta}-peptides into neurotoxic oligomers is a key feature in the development of Alzheimers disease. Mounting evidence suggests that the neuronal cell membrane is the main site of oligomer-mediated neuronal toxicity. To gain a detailed understanding of the mutual effects of amyloid-{beta} oligomers and the neuronal membrane, we carried out a total of 12 {micro}s all-atom molecular dynamics (MD) simulations of the dimerization of the full-length A{beta}42 peptide in the presence of a lipid bilayer mimicking the in vivo composition of neuronal membranes. The conformational changes of A{beta}42 resulting from its dimerization and interactions with the neuronal membrane are compared to those occurring upon its dimerization in the aqueous phase, which is also tested by 12 {micro}s of MD simulations. We find that the interactions with the neuronal membrane decrease the order of the A{beta}42 dimer by attenuating its propensity to form a {beta}-sheet structure. The main lipid interaction partners of A{beta}42 are the surface-exposed sugar groups of the gangliosides GM1. A{beta}42 dimerization in solution, on the other hand, is characterized by a random coil to {beta}-sheet transition that seems to be on-pathway to amyloid aggregation. As the neurotoxic activity of amyloid oligomers increases with oligomer order, the results suggest that GM1 is neuroprotective against A{beta}-mediated toxicity by inhibiting the formation of ordered amyloid oligomers.

biophysics↗